André Birgy
Impact in
- Molecular Medicine top 0.5%
- Antibiotic Resistance in Bacteria
- Endocrinology top 1%
- Escherichia coli research studies
- Enterobacteriaceae and Cronobacter Research
Papers in
-
- Antibiotic Resistance in Bacteria 35
-
- Escherichia coli research studies 13
- Enterobacteriaceae and Cronobacter Research 7
- Co-authors
- Stéphane Bonacorsi (33 shared papers)Philippe Bidet (23 shared papers)Olivier Tenaillon (10 shared papers)Claire Amaris Hobson (15 shared papers)Hervé Jacquier (6 shared papers)Céline Courroux (10 shared papers)Béatrice Berçot (7 shared papers)Édouard Bingen (4 shared papers)
- Journals
- Antimicrobial Agents and Chemotherapy (8 papers)Journal of Clinical Microbiology (6 papers)Journal of Antimicrobial Chemotherapy (4 papers)Scientific Reports (2 papers)Clinical Microbiology and Infection (2 papers)
- Partner nations
- FranceUnited StatesSwitzerland
In The Last Decade
André Birgy
45 papers receiving 1.1k citations
André Birgy's Hit Papers
Peers
Comparison fields: 5 of 69
- Molecular Medicine 698
- Endocrinology 372
- Applied Microbiology and Biotechnology 137
- Clinical Biochemistry 134
- Pharmacology 254
Countries citing papers authored by André Birgy
This map shows the geographic impact of André Birgy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by André Birgy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites André Birgy more than expected).
Fields of papers citing papers by André Birgy
This network shows the impact of papers produced by André Birgy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by André Birgy. The network helps show where André Birgy may publish in the future.
Co-authors
The 25 scholars most cited alongside André Birgy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 48 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 168 | |
| 2 | Klebsiella pneumoniae Carbapenemase Variants Resistant to Ceftazidime-Avibactam: an Evolutionary Overview Hit paper breakdown → | 2022 | 128 |
| 3 | 2012 | 91 | |
| 4 | 2021 | 80 | |
| 5 | 2012 | 77 | |
| 6 | 2023 | 60 | |
| 7 | 2018 | 54 | |
| 8 | 2016 | 46 | |
| 9 | 2011 | 41 | |
| 10 | 2013 | 41 | |
| 11 | 2020 | 33 | |
| 12 | 2022 | 25 | |
| 13 | 2019 | 23 | |
| 14 | 2020 | 22 | |
| 15 | 2018 | 22 | |
| 16 | 2019 | 19 | |
| 17 | 2019 | 18 | |
| 18 | 2018 | 18 | |
| 19 | 2019 | 13 | |
| 20 | 2024 | 11 |
About André Birgy
André Birgy is a scholar working on Molecular Medicine, Endocrinology, Epidemiology, Infectious Diseases and Pharmacology, having authored 48 papers that have together received 1.1k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (35 papers), Escherichia coli research studies (13 papers), Antibiotics Pharmacokinetics and Efficacy (11 papers), Bacterial Identification and Susceptibility Testing (7 papers), Enterobacteriaceae and Cronobacter Research (7 papers), Clostridium difficile and Clostridium perfringens research (6 papers), Pharmaceutical and Antibiotic Environmental Impacts (5 papers) and Urinary Tract Infections Management (5 papers). The work is most often cited by research in Molecular Medicine (698 citations), Endocrinology (372 citations), Applied Microbiology and Biotechnology (137 citations), Clinical Biochemistry (134 citations) and Pharmacology (254 citations). André Birgy has collaborated with scholars based in France, United States and Switzerland. Frequent co-authors include Stéphane Bonacorsi, Philippe Bidet, Olivier Tenaillon, Claire Amaris Hobson, Hervé Jacquier, Céline Courroux, Béatrice Berçot, Édouard Bingen, Aurélie Cointe and C. Doit. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Journal of Clinical Microbiology, Journal of Antimicrobial Chemotherapy, Scientific Reports and Clinical Microbiology and Infection.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.